Pharm-话题@MedSci

#Pharm#

730篇内容 | 2552人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1787792, encodeId=81bc1e877925c, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Rhizen Pharmaceuticals AG在2022年欧洲肿瘤内科学会乳腺癌会议上公布一项进行中的Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌患者II期研究的中期积极数据, objectType=article, longId=726291, objectId=eddae262914c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eddae262914c, replyNumber=0, likeNumber=73, createdTime=2022-10-16, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eddae262914c, moduleTitle=Rhizen Pharmaceuticals AG在2022年欧洲肿瘤内科学会乳腺癌会议上公布一项进行中的Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌患者II期研究的中期积极数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eddae262914c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787730, encodeId=b6fb1e8773072, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Aliment Pharmacol Ther：雷尼替丁是否会增加消化道癌症的风险？, objectType=article, longId=214801, objectId=b57b21480116, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b57b21480116, replyNumber=0, likeNumber=65, createdTime=2021-12-11, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b57b21480116, moduleTitle=Aliment Pharmacol Ther：雷尼替丁是否会增加消化道癌症的风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b57b21480116)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787773, encodeId=67361e8777333, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Alvotech与BiosanaPharma达成全球独家许可协议，共同开发Xolair®（奥马珠单抗）的拟议生物仿制药(AVT23), objectType=article, longId=295364, objectId=dce229536434, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dce229536434, replyNumber=0, likeNumber=76, createdTime=2022-06-04, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dce229536434, moduleTitle=Alvotech与BiosanaPharma达成全球独家许可协议，共同开发Xolair®（奥马珠单抗）的拟议生物仿制药(AVT23), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dce229536434)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787761, encodeId=68e41e87761e1, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Front Pharmacol：microRNA在肺栓塞中的作用, objectType=article, longId=219945, objectId=d7e2219945a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7e2219945a9, replyNumber=0, likeNumber=52, createdTime=2022-07-24, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7e2219945a9, moduleTitle=Front Pharmacol：microRNA在肺栓塞中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7e2219945a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787749, encodeId=d9c31e87749f3, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Pharmacol Ther：睡眠呼吸暂停和肺动脉高压：一个有待解决的谜语, objectType=article, longId=218101, objectId=f8862181012d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8862181012d, replyNumber=0, likeNumber=129, createdTime=2022-04-23, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8862181012d, moduleTitle=Pharmacol Ther：睡眠呼吸暂停和肺动脉高压：一个有待解决的谜语, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8862181012d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787755, encodeId=9e0d1e8775553, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Eur J Pharm Biopharm：新型阿莫达非尼微针贴片对睡眠剥夺负面影响的改善作用, objectType=article, longId=219399, objectId=2c93219399f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c93219399f1, replyNumber=0, likeNumber=85, createdTime=2022-04-23, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c93219399f1, moduleTitle=Eur J Pharm Biopharm：新型阿莫达非尼微针贴片对睡眠剥夺负面影响的改善作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c93219399f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787733, encodeId=09501e87733e2, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Aliment Pharmacol Ther：维多珠单抗治疗炎症性肠病的长期安全性, objectType=article, longId=215086, objectId=002b2150863d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=002b2150863d, replyNumber=0, likeNumber=70, createdTime=2022-05-09, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=002b2150863d, moduleTitle=Aliment Pharmacol Ther：维多珠单抗治疗炎症性肠病的长期安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=002b2150863d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787731, encodeId=586f1e8773185, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Aliment Pharmacol Ther：高危HLA基因型是高危亲属患乳糜泻重要的个体风险因素, objectType=article, longId=214803, objectId=020d214803be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=020d214803be, replyNumber=0, likeNumber=72, createdTime=2021-08-19, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=020d214803be, moduleTitle=Aliment Pharmacol Ther：高危HLA基因型是高危亲属患乳糜泻重要的个体风险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=020d214803be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787723, encodeId=aba61e87723e4, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Neuropsychopharmacology:人巨细胞病毒感染与重度抑郁症患者白质FA降低之间存在可复制关联, objectType=article, longId=213444, objectId=485d213444a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=485d213444a1, replyNumber=0, likeNumber=77, createdTime=2021-10-21, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=485d213444a1, moduleTitle=Neuropsychopharmacology:人巨细胞病毒感染与重度抑郁症患者白质FA降低之间存在可复制关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=485d213444a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787769, encodeId=35c91e877696a, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Skin Pharmacol Physiol：壳聚糖凝胶可有效减少皮肤出油, objectType=article, longId=294067, objectId=a62929406e9f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a62929406e9f, replyNumber=0, likeNumber=76, createdTime=2022-08-26, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a62929406e9f, moduleTitle=Skin Pharmacol Physiol：壳聚糖凝胶可有效减少皮肤出油, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a62929406e9f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787718, encodeId=21701e877187a, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Front Pharmacol：间羟胺预防剖宫产术中脊麻性低血压的随机双盲剂量依赖性研究, objectType=article, longId=212839, objectId=48a921283922, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48a921283922, replyNumber=0, likeNumber=60, createdTime=2021-12-01, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48a921283922, moduleTitle=Front Pharmacol：间羟胺预防剖宫产术中脊麻性低血压的随机双盲剂量依赖性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=48a921283922)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787782, encodeId=36ef1e8778281, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Biomed Pharmacother：中药复方菩人丹可减轻老年2型糖尿病大鼠非酒精性脂肪性肝病, objectType=article, longId=301471, objectId=60643014e1be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60643014e1be, replyNumber=0, likeNumber=84, createdTime=2022-08-23, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60643014e1be, moduleTitle=Biomed Pharmacother：中药复方菩人丹可减轻老年2型糖尿病大鼠非酒精性脂肪性肝病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60643014e1be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787743, encodeId=85741e87743ed, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Frontiers pharmacol：中医药治疗抑郁症合并糖尿病前景光明, objectType=article, longId=217602, objectId=1aa221e602d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1aa221e602d9, replyNumber=0, likeNumber=66, createdTime=2022-02-05, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1aa221e602d9, moduleTitle=Frontiers pharmacol：中医药治疗抑郁症合并糖尿病前景光明, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1aa221e602d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787736, encodeId=bc831e87736d9, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Biomed Pharmacother：中医药联合肺部给药系统防治特发性肺纤维化可行性探讨, objectType=article, longId=215787, objectId=0a39215e873e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a39215e873e, replyNumber=0, likeNumber=71, createdTime=2022-04-18, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a39215e873e, moduleTitle=Biomed Pharmacother：中医药联合肺部给药系统防治特发性肺纤维化可行性探讨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a39215e873e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787752, encodeId=dbcd1e877528d, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Rhizen Pharmaceuticals AG宣布在Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌的II期研究中首次向患者给药, objectType=article, longId=218658, objectId=c75f218658a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c75f218658a9, replyNumber=0, likeNumber=109, createdTime=2022-07-10, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c75f218658a9, moduleTitle=Rhizen Pharmaceuticals AG宣布在Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌的II期研究中首次向患者给药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c75f218658a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787717, encodeId=c81b1e8771729, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Front Pharmacol：通过转录组学和网络特征预测前列腺癌的协同药物组合研究, objectType=article, longId=212065, objectId=c016212065e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c016212065e2, replyNumber=0, likeNumber=84, createdTime=2022-04-16, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c016212065e2, moduleTitle=Front Pharmacol：通过转录组学和网络特征预测前列腺癌的协同药物组合研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c016212065e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787751, encodeId=3f881e8775159, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=武田与JCR Pharmaceuticals合作，将亨特综合征下一代治疗药物商业化, objectType=article, longId=218421, objectId=20732184217a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20732184217a, replyNumber=0, likeNumber=88, createdTime=2022-04-03, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20732184217a, moduleTitle=武田与JCR Pharmaceuticals合作，将亨特综合征下一代治疗药物商业化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20732184217a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787762, encodeId=ade21e8776274, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=ENYO Pharma宣布将在AASLD肝脏会议上发布两项Vonafexor数据报告, objectType=article, longId=219978, objectId=74472199e8cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74472199e8cf, replyNumber=0, likeNumber=80, createdTime=2022-03-22, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74472199e8cf, moduleTitle=ENYO Pharma宣布将在AASLD肝脏会议上发布两项Vonafexor数据报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74472199e8cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787772, encodeId=d34d1e877726a, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Int J Pharm:芍药苷-磷脂复合物胶束可改善胆汁淤滞性肝损伤, objectType=article, longId=294797, objectId=37fa294e9750, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37fa294e9750, replyNumber=0, likeNumber=80, createdTime=2022-03-05, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37fa294e9750, moduleTitle=Int J Pharm:芍药苷-磷脂复合物胶束可改善胆汁淤滞性肝损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37fa294e9750)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787775, encodeId=1fc21e87775a6, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Front Pharmacol ：采样时间变异对小儿原发性肾病综合征他克莫司剂量方案的影响, objectType=article, longId=295670, objectId=62492956e0b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62492956e0b7, replyNumber=0, likeNumber=60, createdTime=2022-07-06, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62492956e0b7, moduleTitle=Front Pharmacol ：采样时间变异对小儿原发性肾病综合征他克莫司剂量方案的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62492956e0b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Pharm

2020-05-29

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Rhizen Pharmaceuticals AG在2022年欧洲肿瘤内科学会乳腺癌会议上公布一项进行中的Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌患者II期研究的中期积极数据

2022-10-16

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Aliment Pharmacol Ther：雷尼替丁是否会增加消化道癌症的风险？

2021-12-11

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Alvotech与BiosanaPharma达成全球独家许可协议，共同开发Xolair®（奥马珠单抗）的拟议生物仿制药(AVT23)

2022-06-04

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Front Pharmacol：microRNA在肺栓塞中的作用

2022-07-24

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Pharmacol Ther：睡眠呼吸暂停和肺动脉高压：一个有待解决的谜语

2022-04-23

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Eur J Pharm Biopharm：新型阿莫达非尼微针贴片对睡眠剥夺负面影响的改善作用

2022-04-23

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Aliment Pharmacol Ther：维多珠单抗治疗炎症性肠病的长期安全性

2022-05-09

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Aliment Pharmacol Ther：高危HLA基因型是高危亲属患乳糜泻重要的个体风险因素

2021-08-19

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Neuropsychopharmacology:人巨细胞病毒感染与重度抑郁症患者白质FA降低之间存在可复制关联

2021-10-21

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Skin Pharmacol Physiol：壳聚糖凝胶可有效减少皮肤出油

2022-08-26

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Front Pharmacol：间羟胺预防剖宫产术中脊麻性低血压的随机双盲剂量依赖性研究

2021-12-01

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Biomed Pharmacother：中药复方菩人丹可减轻老年2型糖尿病大鼠非酒精性脂肪性肝病

2022-08-23

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Frontiers pharmacol：中医药治疗抑郁症合并糖尿病前景光明

2022-02-05

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Biomed Pharmacother：中医药联合肺部给药系统防治特发性肺纤维化可行性探讨

2022-04-18

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Rhizen Pharmaceuticals AG宣布在Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌的II期研究中首次向患者给药

2022-07-10

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Front Pharmacol：通过转录组学和网络特征预测前列腺癌的协同药物组合研究

2022-04-16

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

武田与JCR Pharmaceuticals合作，将亨特综合征下一代治疗药物商业化

2022-04-03

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

ENYO Pharma宣布将在AASLD肝脏会议上发布两项Vonafexor数据报告

2022-03-22

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Int J Pharm:芍药苷-磷脂复合物胶束可改善胆汁淤滞性肝损伤

2022-03-05

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Front Pharmacol ：采样时间变异对小儿原发性肾病综合征他克莫司剂量方案的影响

2022-07-06

科室
- - 订阅+
  - 更多科室
工具
服务